ZEJULA 200 mg/1

ZEJULA 200 mg tablets are a prescription medication used for specific therapeutic purposes. This film-coated tablet is manufactured by GlaxoSmithKline LLC in the USA.

ZEJULA is primarily used in the management of certain types of cancer. It is often prescribed for patients who have specific genetic markers or mutations. The medication works by targeting particular enzymes involved in DNA repair, which can help in controlling the growth of cancer cells. Patients should consult their healthcare provider to determine if ZEJULA is suitable for their condition.

Common effects of ZEJULA may include fatigue, nausea, and anemia. Some patients might experience vomiting, constipation, or thrombocytopenia. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

ZEJULA should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any other medications they are taking to avoid potential interactions.

ZEJULA may interact with certain medications, including strong CYP3A inhibitors and inducers. It is important to discuss all current medications with a healthcare provider to ensure safe and effective use. Alcohol and other substances may also affect the efficacy of ZEJULA.